$SGP
SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA.
Healthcare
Sector
Biotechnology
Industry
Patrick Mooney
CEO
$29.13
Current Price
$949.55M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 15 | 17 | $221,480,000.00 | 13,842,500 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 15 | 17 | $221,480,000.00 | 13,842,500 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 9, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | 3,441,966 | $16.00 | $55,071,456.00 | View Details |
| Feb 9, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | 248,034 | $16.00 | $3,968,544.00 | View Details |
| Feb 9, 2026 | Behbahani Ali Director | Purchase | 937,500 | $16.00 | $15,000,000.00 | View Details |
| Feb 9, 2026 | Florence Anthony A. Jr. 10% Owner | Purchase | 937,500 | $16.00 | $15,000,000.00 | View Details |
| Feb 9, 2026 | BASKETT FOREST 10% Owner | Purchase | 937,500 | $16.00 | $15,000,000.00 | View Details |
| Feb 9, 2026 | New Enterprise Associates 17, L.P. 10% Owner | Purchase | 937,500 | $16.00 | $15,000,000.00 | View Details |
| Feb 9, 2026 | Yang Rick 10% Owner | Purchase | 937,500 | $16.00 | $15,000,000.00 | View Details |
| Feb 9, 2026 | Makhzoumi Mohamad 10% Owner | Purchase | 937,500 | $16.00 | $15,000,000.00 | View Details |
| Feb 9, 2026 | SANDELL SCOTT D 10% Owner | Purchase | 937,500 | $16.00 | $15,000,000.00 | View Details |
| Feb 9, 2026 | Chang Carmen 10% Owner | Purchase | 937,500 | $16.00 | $15,000,000.00 | View Details |
| Feb 9, 2026 | Walker Paul Edward 10% Owner | Purchase | 937,500 | $16.00 | $15,000,000.00 | View Details |
| Feb 9, 2026 | Mathers Edward T 10% Owner | Purchase | 937,500 | $16.00 | $15,000,000.00 | View Details |
| Feb 9, 2026 | Pardo Geoffrey B Director | Purchase | 312,500 | $16.00 | $5,000,000.00 | View Details |
| Feb 9, 2026 | Khan Bilal Arshad Director | Purchase | 115,000 | $16.00 | $1,840,000.00 | View Details |
| Feb 9, 2026 | Khan Bilal Arshad Director | Purchase | 20,000 | $16.00 | $320,000.00 | View Details |
| Feb 9, 2026 | Nielsen Kirk G. Director | Purchase | 165,000 | $16.00 | $2,640,000.00 | View Details |
| Feb 9, 2026 | Vensana Capital I GP, LLC 10% Owner | Purchase | 165,000 | $16.00 | $2,640,000.00 | View Details |
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No past earnings data available
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies:
$CVRX โ CVRx, Inc.via Nielsen Kirk G.$CDTX โ Cidara Therapeutics, Inc.via RA CAPITAL MANAGEMENT, L.P.$WVE โ Wave Life Sciences Ltd.via RA CAPITAL MANAGEMENT, L.P.$SI โ SHOULDER INNOVATIONS, INC.via Pardo Geoffrey B$KRRO โ Korro Bio, Inc.via Yang Rick$CLYM โ Climb Bio, Inc.via RA CAPITAL MANAGEMENT, L.P.$HOWL โ Werewolf Therapeutics, Inc.via RA CAPITAL MANAGEMENT, L.P.$PEPG โ PepGen Inc.via RA CAPITAL MANAGEMENT, L.P.$TYRA โ Tyra Biosciences, Inc.via RA CAPITAL MANAGEMENT, L.P.$MLYS โ Mineralys Therapeutics, Inc.via RA CAPITAL MANAGEMENT, L.P.